AVMXY Stock, Avita Medical Information

Avita Medical s patented and proprietary collection and application technology provides innovative treatment solutions derived from the regenerative properties of a patients own skin. Our medical devices work by preparing a Regenerative Epithelial Suspension RES , an autologous suspension comprised of the patients own skin cells and wound healing factors that are necessary to regenerate natural healthy skin. This is then applied to the area to be treated. In all countries outside of Europe, our portfolio is marketed under the ReCell brand to promote skin healing in a wide range of applications including burns, chronic wounds and aesthetics. ReCell is TGA registered in Australia, and CFDA cleared in China. In the United States, ReCell is an investigational device limited by federal law to investigational use. In Europe, our portfolio of medical device products received CE mark approval as three tailored product presentations, with three individual brand names. ReCell is designed for the treatment of burns and plastic reconstructive procedures ReGenerCell has been formulated for chronic wounds including leg and foot ulcers and ReNovaCell is tailored for aesthetic applications including the restoration of pigmentation.